Skip to Content
Merck
CN
  • Protocol for Differentiation of Human iPSCs into Pulmonary Neuroendocrine Cells.

Protocol for Differentiation of Human iPSCs into Pulmonary Neuroendocrine Cells.

STAR protocols (2020-10-29)
Pooja Hor, Justin K Ichida, Zea Borok, Amy L Ryan
ABSTRACT

Pulmonary neuroendocrine cells (PNECs) are sensory cells within the lung airway epithelia. Here, we provide a detailed protocol for generating induced PNECs (iPNECs) from human induced pluripotent stem cells (iPSCs). The cellular and molecular profile of iPNECs resembles primary human PNECs. Primary human PNECs are exceedingly rare, comprising only 1% of the adult lung. Therefore, a self-renewing source of patient-specific iPNECs facilitates the creation of reproducible human cellular models to study lung diseases characterized by PNEC dysfunction. For complete details on the use and execution of this protocol, please refer to Hor et al. (2020).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-Vimentin antibody produced in mouse, clone V9, ascites fluid
Sigma-Aldrich
(±)-Epinephrine hydrochloride